학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 12건 | 목록 1~10
Academic Journal
Yap TA; University of Texas MD Anderson Cancer Center, Houston, Texas.; LoRusso PM; Yale Cancer Center, New Haven, Connecticut.; Wong DJ; UCLA Jonsson Comprehensive Cancer Center, Los Angeles California.; Hu-Lieskovan S; UCLA Jonsson Comprehensive Cancer Center, Los Angeles California.; Papadopoulos KP; South Texas Research Accelerated Therapeutics (START), San Antonio, Texas.; Holz JB; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Grabowska U; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Gradinaru C; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Leung KM; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Marshall S; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Reader CS; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Russell R; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Sainson RCA; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Seal CJ; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Shepherd CJ; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Germaschewski F; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Gliddon D; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Stern O; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Young L; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Brewis N; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Kayitalire L; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.; Morrow M; F-star Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Cheng WK; Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, Malaysia.; Oon CE; Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, Malaysia. Electronic address: chern.oon@usm.my.; Kaur G; Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, Malaysia.; Sainson RCA; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Li JL; Wenzhou Medical University School of Biomedical Engineering and Eye Hospital, UCAS Wenzhou Institute, Wenzhou 325035, China; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom; Plymouth University Peninsula School of Medicine, Plymouth, United Kingdom. Electronic address: jlilab1971@yahoo.co.uk.
Publisher: Academic Press Country of Publication: United States NLM ID: 0165035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9319 (Electronic) Linking ISSN: 00262862 NLM ISO Abbreviation: Microvasc Res Subsets: MEDLINE
Academic Journal
Lu LC; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, lichun0519@gmail.com.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, lichun0519@gmail.com.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan, lichun0519@gmail.com.; Deantonio C; Kymab Ltd, Cambridge, United Kingdom.; Palu CC; Kymab Ltd, Cambridge, United Kingdom.; Lee YH; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.; Mitchell LS; Kymab Ltd, Cambridge, United Kingdom.; Cowan M; OracleBio Ltd, BioCity Scotland, Glasgow, United Kingdom.; Corser M; OracleBio Ltd, BioCity Scotland, Glasgow, United Kingdom.; Sherry L; OracleBio Ltd, BioCity Scotland, Glasgow, United Kingdom.; Cheng AL; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.; Quaratino S; Kymab Ltd, Cambridge, United Kingdom.; Shao YY; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Sainson RCA; Kymab Ltd, Cambridge, United Kingdom.; Hsu CH; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232 (Electronic) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE
Academic Journal
Sainson RCA; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom. richard.sainson@kymab.com.; Thotakura AK; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Kosmac M; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Borhis G; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Parveen N; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Kimber R; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Carvalho J; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Henderson SJ; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Pryke KL; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Okell T; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; O'Leary S; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Ball S; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Van Krinks C; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Gamand L; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Taggart E; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Pring EJ; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Ali H; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Craig H; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Wong VWY; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Liang Q; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Rowlands RJ; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Lecointre M; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Campbell J; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Kirby I; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Melvin D; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Germaschewski V; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Oelmann E; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; Quaratino S; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.; McCourt M; Kymab Ltd, Babraham Research Campus, Cambridge, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Academic Journal
Xie B; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Tomaszewski MR; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Neves AA; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Ros S; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Hu DE; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; McGuire S; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Mullins SR; MedImmune Limited, Cambridge, United Kingdom.; Tice D; MedImmune LLC, Gaithersburg, Maryland.; Sainson RCA; MedImmune Limited, Cambridge, United Kingdom.; Bohndiek SE; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Wilkinson RW; MedImmune Limited, Cambridge, United Kingdom.; Brindle KM; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. kmb1001@cam.ac.uk.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Oon CE; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Penang, Malaysia.; Bridges E; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Sheldon H; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Sainson RCA; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Jubb A; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Turley H; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Leek R; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Buffa F; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Harris AL; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Li JL; Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.; Institute of Translational and Stratified Medicine, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, UK.
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Academic Journal
TISSUE ENGINEERING; JAN 2005, 11 1-2, p257-p266, 10p.
검색 결과 제한하기
제한된 항목
[검색어] Sainson, RCA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어